- Home
- HUMAW vs LANC Comparison
HUMAW vs LANC Comparison
Compare HUMAW & LANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- LANC
- Stock Information
- Founded
- HUMAW 2004
- LANC 1961
- Country
- HUMAW United States
- LANC United States
- Employees
- HUMAW 185
- LANC N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- LANC Packaged Foods
- Sector
- HUMAW Health Care
- LANC Consumer Staples
- Exchange
- HUMAW Nasdaq
- LANC Nasdaq
- Market Cap
- HUMAW N/A
- LANC N/A
- IPO Year
- HUMAW N/A
- LANC N/A
- Fundamental
- Price
- HUMAW $0.34
- LANC $191.50
- Analyst Decision
- HUMAW
- LANC Buy
- Analyst Count
- HUMAW 0
- LANC 4
- Target Price
- HUMAW N/A
- LANC $211.33
- AVG Volume (30 Days)
- HUMAW 14.2K
- LANC 168.8K
- Earning Date
- HUMAW 03-21-2025
- LANC 04-30-2025
- Dividend Yield
- HUMAW N/A
- LANC 1.97%
- EPS Growth
- HUMAW N/A
- LANC 21.25
- EPS
- HUMAW N/A
- LANC 5.69
- Revenue
- HUMAW N/A
- LANC $1,900,130,000.00
- Revenue This Year
- HUMAW N/A
- LANC $5.03
- Revenue Next Year
- HUMAW N/A
- LANC $3.31
- P/E Ratio
- HUMAW N/A
- LANC $33.88
- Revenue Growth
- HUMAW N/A
- LANC 1.77
- 52 Week Low
- HUMAW $1.18
- LANC $163.20
- 52 Week High
- HUMAW $1.34
- LANC $202.63
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- LANC 64.50
- Support Level
- HUMAW N/A
- LANC $181.55
- Resistance Level
- HUMAW N/A
- LANC $193.40
- Average True Range (ATR)
- HUMAW 0.00
- LANC 6.00
- MACD
- HUMAW 0.00
- LANC 1.70
- Stochastic Oscillator
- HUMAW 0.00
- LANC 91.57
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.